{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:21:55Z","timestamp":1785763315362,"version":"3.56.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","award":["Prot 317A\/I"],"award-info":[{"award-number":["Prot 317A\/I"]}],"id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["Gruppi di Ricerca 2020 A0375-2020-36663 GecoBiomark"],"award-info":[{"award-number":["Gruppi di Ricerca 2020 A0375-2020-36663 GecoBiomark"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2\u00a0years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase. We are particularly concerned by the lack of solid information from the initial phases of the pandemic that highlighted the necessity for better preparation to face similar future threats. On the other hand, we are gratified by the progress into human genetic susceptibility investigations and we believe now is the time to explore the transition from the pandemic to the endemic phase. The latter will require worldwide vigilance and cooperation, especially in emerging countries. In the transition to the endemic phase, vaccination rates have lagged and developed countries should assist, as warranted, in bolstering vaccination rates worldwide. We also discuss the current status of vaccines and the outlook for COVID-19.<\/jats:p>","DOI":"10.1186\/s40246-022-00392-1","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:02:52Z","timestamp":1654066972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["COVID-19 2022 update: transition of the pandemic to the endemic phase"],"prefix":"10.1186","volume":"16","author":[{"given":"Michela","family":"Biancolella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito Luigi","family":"Colona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruty","family":"Mehrian-Shai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Lee","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Luzzatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen K. V.","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"1","key":"392_CR1","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360.","journal-title":"Acta Biomed"},{"key":"392_CR2","unstructured":"National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. CDC COVID-19 Science Briefs. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020\u2013. Science Brief: Omicron (B.1.1.529) Variant. 2021 Dec 2."},{"issue":"1","key":"392_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/iwj.13739","volume":"19","author":"D Queen","year":"2022","unstructured":"Queen D. Another year another variant: COVID 3.0-omicron. Int Wound J. 2022;19(1):5. https:\/\/doi.org\/10.1111\/iwj.13739.","journal-title":"Int Wound J"},{"key":"392_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","volume":"116","author":"F Abdullah","year":"2022","unstructured":"Abdullah F, Myers J, Basu D, Tintinger G, Ueckermann V, Mathebula M, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int J Infect Dis. 2022;116:38\u201342. https:\/\/doi.org\/10.1016\/j.ijid.2021.12.357 (Epub 2021 Dec 28).","journal-title":"Int J Infect Dis"},{"issue":"1","key":"392_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40246-021-00356-x.Erratum.In:HumGenomics.2021Sep18;15(1):59","volume":"15","author":"VL Colona","year":"2021","unstructured":"Colona VL, Vasiliou V, Watt J, Novelli G, Reichardt JKV. Update on human genetic susceptibility to COVID-19: susceptibility to virus and response. Hum Genom. 2021;15(1):57. https:\/\/doi.org\/10.1186\/s40246-021-00356-x.Erratum.In:HumGenomics.2021Sep18;15(1):59.","journal-title":"Hum Genom"},{"key":"392_CR6","doi-asserted-by":"publisher","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533\u2013534. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1. Epub 2020 Feb 19. Erratum in: Lancet Infect Dis. 2020; 20(9):e215.","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"392_CR7","first-page":"121","volume":"6","author":"\u00c1 O'Toole","year":"2021","unstructured":"O\u2019Toole \u00c1, Hill V, Pybus OG, Watts A, Bogoch II, Khan K, et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351\/501Y-V2 with grinch. Wellcome Open Res. 2021;6:121.","journal-title":"Wellcome Open Res"},{"key":"392_CR8","unstructured":"CDC. Centers for disease control and prevention. Covid.cdc.gov \u201cCovid.cdc.gov \u201c.2022; Retrieved 19\/04, 2022, from https:\/\/covid.cdc.gov\/covid-data-tracker."},{"key":"392_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2200133","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, et al. Protection against the Omicron variant from previous SARS-CoV-2 Infection. N Engl J Med. 2022. https:\/\/doi.org\/10.1056\/NEJMc2200133.","journal-title":"N Engl J Med"},{"key":"392_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2022.03.010","author":"C Chaguza","year":"2022","unstructured":"Chaguza C, Coppi A, Earnest R, Ferguson D, Kerantzas N, Warner F, et al. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons. Med (N Y). 2022. https:\/\/doi.org\/10.1016\/j.medj.2022.03.010.","journal-title":"Med (N Y)"},{"key":"392_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4947","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022. https:\/\/doi.org\/10.1126\/science.abn4947.","journal-title":"Science"},{"key":"392_CR12","unstructured":"COVID-19 Reinfection Data (2022). Retrieved 19\/04; 2022, from https:\/\/coronavirus.health.ny.gov\/covid-19-reinfection-data."},{"issue":"1","key":"392_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40246-021-00326-3","volume":"15","author":"G Novelli","year":"2021","unstructured":"Novelli G, Biancolella M, Mehrian-Shai R, Colona VL, Brito AF, Grubaugh ND, et al. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genom. 2021;15(1):27. https:\/\/doi.org\/10.1186\/s40246-021-00326-3.","journal-title":"Hum Genom"},{"issue":"4","key":"392_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMc2117385","volume":"386","author":"K Muhsen","year":"2022","unstructured":"Muhsen K, Maimon N, Mizrahi A, Varticovschi B, Bodenheimer O, Gelbshtein U, et al. Effects of BNT162b2 Covid-19 vaccine booster in long-term care facilities in Israel. N Engl J Med. 2022;386(4):399\u2013401. https:\/\/doi.org\/10.1056\/NEJMc2117385 (Epub 2021 Dec 22).","journal-title":"N Engl J Med"},{"issue":"20","key":"392_CR15","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2021.19499","volume":"326","author":"MW Tenforde","year":"2021","unstructured":"Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, et al. Influenza and other viruses in the acutely Ill (IVY) network association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043\u201354. https:\/\/doi.org\/10.1001\/jama.2021.19499.","journal-title":"JAMA"},{"issue":"10","key":"392_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","volume":"21","author":"JS Tregoning","year":"2021","unstructured":"Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626\u201336. https:\/\/doi.org\/10.1038\/s41577-021-00592-1 (Epub 2021 Aug 9).","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"392_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMc2119270","volume":"386","author":"S Collie","year":"2022","unstructured":"Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N Engl J Med. 2022;386(5):494\u20136. https:\/\/doi.org\/10.1056\/NEJMc2119270 (Epub 2021 Dec 29).","journal-title":"N Engl J Med"},{"issue":"7887","key":"392_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-021-04130-w","volume":"600","author":"JT Davis","year":"2021","unstructured":"Davis JT, Chinazzi M, Perra N, Mu K, Pastore Y, Piontti A, et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature. 2021;600(7887):127\u201332. https:\/\/doi.org\/10.1038\/s41586-021-04130-w.","journal-title":"Nature"},{"issue":"10229","key":"392_CR19","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S0140-6736(20)30630-9","volume":"395","author":"MS Green","year":"2020","unstructured":"Green MS. Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? Lancet. 2020;395(10229):1034\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(20)30630-9 (Epub 2020 Mar 13).","journal-title":"Lancet"},{"key":"392_CR20","unstructured":"WHO. World Health Organization. Who.int \u201cwho.int\u201d. 2022; Retrieved 19\/04, 2022, from https:\/\/www.who.int\/news\/item\/13-10-2021-who-announces-proposed-members-of-its-scientific-advisory-group-for-the-origins-of-novel-pathogens-(sago)."},{"issue":"7892","key":"392_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41586-022-00057-y","volume":"601","author":"COVID is here to stay","year":"2022","unstructured":"COVID is here to stay. countries must decide how to adapt. Nature. 2022;601(7892):165. https:\/\/doi.org\/10.1038\/d41586-022-00057-y.","journal-title":"Nature"},{"issue":"7895","key":"392_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41586-022-00210-7","volume":"602","author":"D Adam","year":"2022","unstructured":"Adam D. Will Omicron end the pandemic? Here\u2019s What Experts Say Nature. 2022;602(7895):20\u20131. https:\/\/doi.org\/10.1038\/d41586-022-00210-7.","journal-title":"Here's What Experts Say Nature"},{"key":"392_CR23","unstructured":"Happi CT, Nkengasong JN. Two years of COVID-19 in Africa: lessons for the world. Nature. 2022."},{"key":"392_CR24","unstructured":"Servick K. Is it time to live with COVID-19? Some scientists warn of \u2018endemic delusion\u2019. Science. 2022."},{"issue":"7897","key":"392_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-021-04353-x","volume":"602","author":"VL Hale","year":"2022","unstructured":"Hale VL, Dennis PM, McBride DS, Nolting JM, Madden C, Huey D, et al. SARS-CoV-2 infection in free-ranging white-tailed deer. Nature. 2022;602(7897):481\u20136. https:\/\/doi.org\/10.1038\/s41586-021-04353-x (Epub 2021 Dec 23).","journal-title":"Nature"},{"issue":"12","key":"392_CR26","doi-asserted-by":"publisher","first-page":"693938","DOI":"10.3389\/fimmu.2021.693938","volume":"1","author":"A Kumar","year":"2021","unstructured":"Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, et al. COVID-19 mechanisms in the human body-what we know so far. Front Immunol. 2021;1(12):693938. https:\/\/doi.org\/10.3389\/fimmu.2021.693938.","journal-title":"Front Immunol"},{"issue":"10223","key":"392_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7 (Epub 2020 Jan 30).","journal-title":"Lancet"},{"issue":"5","key":"392_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/tan.14047","volume":"96","author":"A Novelli","year":"2020","unstructured":"Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona VL, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020;96(5):610\u20134. https:\/\/doi.org\/10.1111\/tan.14047 (Epub 2020 Sep 3).","journal-title":"HLA"},{"key":"392_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpeds.2020.05.006","volume":"223","author":"JY Chao","year":"2020","unstructured":"Chao JY, Derespina KR, Herold BC, Goldman DL, Aldrich M, Weingarten J, et al. Clinical characteristics and outcomes of hospitalized and critically Ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York City. J Pediatr. 2020;223:14-19.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.006 (Epub 2020 May 11).","journal-title":"J Pediatr"},{"issue":"12","key":"392_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","volume":"41","author":"AG Harrison","year":"2020","unstructured":"Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41(12):1100\u201315. https:\/\/doi.org\/10.1016\/j.it.2020.10.004 (Epub 2020 Oct 14).","journal-title":"Trends Immunol"},{"key":"392_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04447-0","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Bastard P, Human Genetic Effort COVID, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04447-0.","journal-title":"Nature"},{"issue":"23","key":"392_CR32","doi-asserted-by":"publisher","first-page":"e155011","DOI":"10.1172\/JCI155011","volume":"131","author":"VL Colona","year":"2021","unstructured":"Colona VL, Biancolella M, Novelli A, Novelli G. Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality? J Clin Invest. 2021;131(23):e155011. https:\/\/doi.org\/10.1172\/JCI155011.","journal-title":"J Clin Invest"},{"issue":"10302","key":"392_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","volume":"398","author":"L Huang","year":"2021","unstructured":"Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(21)01755-4.","journal-title":"Lancet"},{"key":"392_CR34","doi-asserted-by":"publisher","unstructured":"Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626\u2013631. https:\/\/doi.org\/10.1038\/s41591-021-01292-y. Epub 2021 Mar 10. Erratum in: Nat Med. 2021; 27(6):1116.","DOI":"10.1038\/s41591-021-01292-y"},{"issue":"3","key":"392_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/jcm11030524","volume":"11","author":"V Visco","year":"2022","unstructured":"Visco V, Vitale C, Rispoli A, Izzo C, Virtuoso N, Ferruzzi GJ, et al. Post-COVID-19 Syndrome: Involvement and Interactions between respiratory, cardiovascular and nervous systems. J Clin Med. 2022;11(3):524. https:\/\/doi.org\/10.3390\/jcm11030524.","journal-title":"J Clin Med"},{"issue":"373","key":"392_CR36","doi-asserted-by":"publisher","first-page":"n1565","DOI":"10.1136\/bmj.n1565","volume":"21","author":"E Fraser","year":"2021","unstructured":"Fraser E. Persistent pulmonary disease after acute covid-19. BMJ. 2021;21(373):n1565. https:\/\/doi.org\/10.1136\/bmj.n1565.","journal-title":"BMJ"},{"issue":"1","key":"392_CR37","doi-asserted-by":"publisher","first-page":"E353","DOI":"10.1148\/radiol.2021210033","volume":"301","author":"JT Grist","year":"2021","unstructured":"Grist JT, Chen M, Collier GJ, Raman B, Abueid G, McIntyre A, et al. Hyperpolarized 129Xe MRI abnormalities in dyspneic patients 3 months after COVID-19 pneumonia: preliminary results. Radiology. 2021;301(1):E353\u201360. https:\/\/doi.org\/10.1148\/radiol.2021210033 (Epub 2021 May 25).","journal-title":"Radiology"},{"issue":"4","key":"392_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pulmoe.2020.10.013","volume":"27","author":"R Torres-Castro","year":"2021","unstructured":"Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328\u201337. https:\/\/doi.org\/10.1016\/j.pulmoe.2020.10.013.","journal-title":"Pulmonology"},{"issue":"4","key":"392_CR39","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z (Epub 2021 Mar 22).","journal-title":"Nat Med"},{"issue":"3","key":"392_CR40","doi-asserted-by":"publisher","first-page":"jrm00164","DOI":"10.2340\/16501977-2805","volume":"53","author":"LC Burgess","year":"2021","unstructured":"Burgess LC, Venugopalan L, Badger J, Street T, Alon G, Jarvis JC, et al. Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: a narrative review. J Rehabil Med. 2021;53(3):jrm00164. https:\/\/doi.org\/10.2340\/16501977-2805.","journal-title":"J Rehabil Med"},{"issue":"12","key":"392_CR41","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1097\/j.pain.0000000000002306","volume":"162","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Rodr\u00edguez-Jim\u00e9nez J, Fuensalida-Novo S, Palacios-Ce\u00f1a M, G\u00f3mez-Mayordomo V, Florencio LL, et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain. 2021;162(12):2832\u201340. https:\/\/doi.org\/10.1097\/j.pain.0000000000002306.","journal-title":"Pain"},{"issue":"8","key":"392_CR42","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/acn3.51416","volume":"8","author":"E Farr","year":"2021","unstructured":"Farr E, Wolfe AR, Deshmukh S, Rydberg L, Soriano R, Walter JM, et al. Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound. Ann Clin Transl Neurol. 2021;8(8):1745\u20139. https:\/\/doi.org\/10.1002\/acn3.51416 (Epub 2021 Jul 11).","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"392_CR43","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.clinph.2021.03.008","volume":"132","author":"B Rodriguez","year":"2021","unstructured":"Rodriguez B, Nansoz S, Cameron DR, Z\u2019Graggen WJ. Is myopathy part of long-Covid? Clin Neurophysiol. 2021;132(6):1241\u20132. https:\/\/doi.org\/10.1016\/j.clinph.2021.03.008 (Epub 2021 Mar 26).","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"392_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/v13040700","volume":"13","author":"B Silva Andrade","year":"2021","unstructured":"Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza RF, Santos NO, Dos Santos FA, et al. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. https:\/\/doi.org\/10.3390\/v13040700.","journal-title":"Viruses"},{"issue":"12","key":"392_CR45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00392-020-01727-5","volume":"109","author":"S St\u00f6be","year":"2020","unstructured":"St\u00f6be S, Richter S, Seige M, Stehr S, Laufs U, Hagendorff A. Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin Res Cardiol. 2020;109(12):1549\u201366. https:\/\/doi.org\/10.1007\/s00392-020-01727-5 (Epub 2020 Aug 14).","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"392_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416\u201327. https:\/\/doi.org\/10.1016\/S2215-0366(21)00084-5 (Epub 2021 Apr 6).","journal-title":"Lancet Psychiatry"},{"key":"392_CR47","doi-asserted-by":"publisher","first-page":"333102421106807","DOI":"10.1177\/03331024211068074","volume":"15","author":"D Garcia-Azorin","year":"2022","unstructured":"Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, et al. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. 2022;15:3331024211068074. https:\/\/doi.org\/10.1177\/03331024211068074.","journal-title":"Cephalalgia"},{"issue":"9","key":"392_CR48","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1474-4422(21)00182-4","volume":"20","author":"MS Xydakis","year":"2021","unstructured":"Xydakis MS, Albers MW, Holbrook EH, Lyon DM, Shih RY, Frasnelli JA, et al. Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol. 2021;20(9):753\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(21)00182-4 (Epub 2021 Jul 30).","journal-title":"Lancet Neurol"},{"issue":"18","key":"392_CR49","first-page":"e14992","volume":"9","author":"A Mazzatenta","year":"2021","unstructured":"Mazzatenta A, Montagnini C, Brasacchio A, Sartucci F, Neri G. Electrophysiological and olfactometric evaluation of long-term COVID-19. Physiol Rep. 2021;9(18):e14992.","journal-title":"Physiol Rep"},{"issue":"9","key":"392_CR50","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.cmi.2021.05.015","volume":"27","author":"E Guedj","year":"2021","unstructured":"Guedj E, Lazarini F, Morbelli S, Ceccaldi M, Hautefort C, Kas A, et al. Long COVID and the brain network of Proust\u2019s madeleine: targeting the olfactory pathway. Clin Microbiol Infect. 2021;27(9):1196\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2021.05.015 (Epub 2021 May 17).","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"392_CR51","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/acn3.51350","volume":"8","author":"EL Graham","year":"2021","unstructured":"Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u201clong haulers.\u201d Ann Clin Transl Neurol. 2021;8(5):1073\u201385. https:\/\/doi.org\/10.1002\/acn3.51350 (Epub 2021 Mar 30).","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"392_CR52","doi-asserted-by":"publisher","first-page":"E1114","DOI":"10.9778\/cmajo.20210023","volume":"9","author":"BJ MacIntosh","year":"2021","unstructured":"MacIntosh BJ, Ji X, Chen JJ, Gilboa A, Roudaia E, Sekuler AB, Gao F, et al. Brain structure and function in people recovering from COVID-19 after hospital discharge or self-isolation: a longitudinal observational study protocol. CMAJ Open. 2021;9(4):E1114\u20139. https:\/\/doi.org\/10.9778\/cmajo.20210023.","journal-title":"CMAJ Open"},{"issue":"18","key":"392_CR53","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/jcm10184142","volume":"10","author":"P Lorkiewicz","year":"2021","unstructured":"Lorkiewicz P, Waszkiewicz N. Biomarkers of Post-COVID depression. J Clin Med. 2021;10(18):4142. https:\/\/doi.org\/10.3390\/jcm10184142.","journal-title":"J Clin Med"},{"issue":"1","key":"392_CR54","doi-asserted-by":"publisher","first-page":"e240178","DOI":"10.1136\/bcr-2020-240178","volume":"14","author":"MM Raahimi","year":"2021","unstructured":"Raahimi MM, Kane A, Moore CE, Alareed AW. Late onset of Guillain-Barr\u00e9 syndrome following SARS-CoV-2 infection: part of \u201clong COVID-19 syndrome\u201d? BMJ Case Rep. 2021;14(1):e240178. https:\/\/doi.org\/10.1136\/bcr-2020-240178.","journal-title":"BMJ Case Rep"},{"issue":"21","key":"392_CR55","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.2169\/internalmedicine.7355-21","volume":"60","author":"T Kakumoto","year":"2021","unstructured":"Kakumoto T, Kobayashi S, Yuuki H, Kainaga M, Shirota Y, Hamada M, et al. Cranial nerve involvement and dysautonomia in post-COVID-19 Guillain-Barr\u00e9 syndrome. Intern Med. 2021;60(21):3477\u201380. https:\/\/doi.org\/10.2169\/internalmedicine.7355-21 (Epub 2021 Aug 24).","journal-title":"Intern Med"},{"issue":"9","key":"392_CR56","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/ene.14383","volume":"27","author":"JA Reyes-Bueno","year":"2020","unstructured":"Reyes-Bueno JA, Garc\u00eda-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Mart\u00ednez-Tom\u00e1s C, et al. Miller-fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020;27(9):1759\u201361. https:\/\/doi.org\/10.1111\/ene.14383.","journal-title":"Eur J Neurol"},{"issue":"6","key":"392_CR57","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5455\/medarh.2021.75.471-474","volume":"75","author":"N Salihefendic","year":"2021","unstructured":"Salihefendic N, Zildzic M, Huseinagic H. Ischemic vasculitis as a cause of brain disorder\u2019s in patients with long Covid: case report. Med Arch. 2021;75(6):471\u20134. https:\/\/doi.org\/10.5455\/medarh.2021.75.471-474.","journal-title":"Med Arch"},{"issue":"1","key":"392_CR58","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1038\/s41598-021-93546-5","volume":"11","author":"N Barizien","year":"2021","unstructured":"Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vall\u00e9e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11(1):14042. https:\/\/doi.org\/10.1038\/s41598-021-93546-5.","journal-title":"Sci Rep"},{"key":"392_CR59","doi-asserted-by":"publisher","first-page":"175909142110576","DOI":"10.1177\/17590914211057635","volume":"13","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro. 2021;13:17590914211057636. https:\/\/doi.org\/10.1177\/17590914211057635.","journal-title":"ASN Neuro"},{"issue":"6","key":"392_CR60","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1017\/S0033291720000999","volume":"51","author":"HX Bo","year":"2021","unstructured":"Bo HX, Li W, Yang Y, Wang Y, Zhang Q, Cheung T, et al. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol Med. 2021;51(6):1052\u20133. https:\/\/doi.org\/10.1017\/S0033291720000999 (Epub 2020 Mar 27).","journal-title":"Psychol Med"},{"issue":"12","key":"392_CR61","doi-asserted-by":"publisher","first-page":"811276","DOI":"10.3389\/fneur.2021.811276","volume":"28","author":"L Gilio","year":"2022","unstructured":"Gilio L, Galifi G, Centonze D, Stampanoni BM. Case report: overlap between long covid and functional neurological disorders. Front Neurol. 2022;28(12):811276. https:\/\/doi.org\/10.3389\/fneur.2021.811276.","journal-title":"Front Neurol"},{"key":"392_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","volume":"87","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2020.03.031 (Epub 2020 Mar 30).","journal-title":"Brain Behav Immun"},{"issue":"5","key":"392_CR63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s13365-020-00903-7","volume":"26","author":"SA Azizi","year":"2020","unstructured":"Azizi SA, Azizi SA. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial\/endothelial cells. J Neurovirol. 2020;26(5):631\u201341. https:\/\/doi.org\/10.1007\/s13365-020-00903-7 (Epub 2020 Sep 2).","journal-title":"J Neurovirol"},{"key":"392_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103512","volume":"70","author":"N Kanberg","year":"2021","unstructured":"Kanberg N, Simr\u00e9n J, Ed\u00e9n A, Andersson LM, Nilsson S, Ashton NJ, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70: 103512. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103512 (Epub 2021 Jul 29).","journal-title":"EBioMedicine"},{"issue":"10","key":"392_CR65","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1111\/epi.16683","volume":"61","author":"E Carroll","year":"2020","unstructured":"Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020;61(10):e135\u20139. https:\/\/doi.org\/10.1111\/epi.16683 (Epub 2020 Sep 18).","journal-title":"Epilepsia"},{"issue":"8","key":"392_CR66","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","volume":"267","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179\u201384. https:\/\/doi.org\/10.1007\/s00415-020-09929-7 (Epub 2020 May 26).","journal-title":"J Neurol"},{"issue":"11","key":"392_CR67","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C, Sperhake JP, Schr\u00f6der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(20)30308-2 (Epub 2020 Oct 5).","journal-title":"Lancet Neurol"},{"key":"392_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04569-5","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04569-5.","journal-title":"Nature"},{"issue":"1","key":"392_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41591-021-01647-5","volume":"28","author":"LT Nolen","year":"2022","unstructured":"Nolen LT, Mukerji SS, Mejia NI. Post-acute neurological consequences of COVID-19: an unequal burden. Nat Med. 2022;28(1):20\u20133. https:\/\/doi.org\/10.1038\/s41591-021-01647-5.","journal-title":"Nat Med"},{"issue":"4","key":"392_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(21)00059-4","volume":"20","author":"The Lancet Neurology","year":"2021","unstructured":"The Lancet Neurology. Long COVID: understanding the neurological effects. Lancet Neurol. 2021;20(4):247. https:\/\/doi.org\/10.1016\/S1474-4422(21)00059-4.","journal-title":"Lancet Neurol"},{"issue":"1","key":"392_CR71","doi-asserted-by":"publisher","first-page":"e00911","DOI":"10.1002\/prp2.911","volume":"10","author":"B Jarrott","year":"2022","unstructured":"Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. \u201cLONG COVID\u201d-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect. 2022;10(1):e00911. https:\/\/doi.org\/10.1002\/prp2.911.","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"392_CR72","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/ijms18102173","volume":"18","author":"S Petrillo","year":"2017","unstructured":"Petrillo S, Piermarini E, Pastore A, Vasco G, Schirinzi T, Carrozzo R, et al. Nrf2-inducers counteract neurodegeneration in frataxin-silenced motor neurons: disclosing new therapeutic targets for Friedreich\u2019s ataxia. Int J Mol Sci. 2017;18(10):2173. https:\/\/doi.org\/10.3390\/ijms18102173.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"392_CR73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27878","volume":"35","author":"S Petrillo","year":"2020","unstructured":"Petrillo S, Schirinzi T, Di Lazzaro G, D\u2019Amico J, Colona VL, Bertini E, et al. Systemic activation of Nrf2 pathway in Parkinson\u2019s disease. Mov Disord. 2020;35(1):180\u20134. https:\/\/doi.org\/10.1002\/mds.27878 (Epub 2019 Nov 4).","journal-title":"Mov Disord"},{"issue":"1","key":"392_CR74","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antiox11010124","volume":"11","author":"T Satoh","year":"2022","unstructured":"Satoh T, Trudler D, Oh CK, Lipton SA. Potential therapeutic use of the rosemary diterpene carnosic acid for alzheimer\u2019s disease, parkinson\u2019s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants (Basel). 2022;11(1):124. https:\/\/doi.org\/10.3390\/antiox11010124.","journal-title":"Antioxidants (Basel)"},{"issue":"34","key":"392_CR75","doi-asserted-by":"publisher","first-page":"e2024358118","DOI":"10.1073\/pnas.2024358118","volume":"118","author":"BD Paul","year":"2021","unstructured":"Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118(34):e2024358118. https:\/\/doi.org\/10.1073\/pnas.2024358118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9-S","key":"392_CR76","first-page":"22","volume":"91","author":"P Rovere Querini","year":"2020","unstructured":"Rovere Querini P, De Lorenzo R, Conte C, Brioni E, Lanzani C, Yacoub MR, et al. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(9-S):22\u20138.","journal-title":"Acta Biomed"},{"issue":"4","key":"392_CR77","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/BCJ20220016","volume":"479","author":"DB Kell","year":"2022","unstructured":"Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537\u201359. https:\/\/doi.org\/10.1042\/BCJ20220016.","journal-title":"Biochem J"},{"issue":"6571","key":"392_CR78","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.abj7965","volume":"374","author":"JL Casanova","year":"2021","unstructured":"Casanova JL, Abel L. Mechanisms of viral inflammation and disease in humans. Science. 2021;374(6571):1080\u20136. https:\/\/doi.org\/10.1126\/science.abj7965.","journal-title":"Science"},{"issue":"1","key":"392_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40246-020-00290-4","volume":"14","author":"C Anastassopoulou","year":"2020","unstructured":"Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genom. 2020;14(1):40. https:\/\/doi.org\/10.1186\/s40246-020-00290-4.","journal-title":"Hum Genom"},{"key":"392_CR80","doi-asserted-by":"publisher","unstructured":"Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nat Immunol. 2021; https:\/\/doi.org\/10.1038\/s41590-021-01030-z. Epub 2021 Oct 18. Erratum in: Nat Immunol. 2021 Nov 24.","DOI":"10.1038\/s41590-021-01030-z"},{"key":"392_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04447-0","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Bastard P, Effort CHG, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04447-0.","journal-title":"Nature"},{"key":"392_CR82","doi-asserted-by":"publisher","first-page":"103806","DOI":"10.1016\/j.ebiom.2021.103806","volume":"75","author":"IM Fink-Baldauf","year":"2022","unstructured":"Fink-Baldauf IM, Stuart WD, Brewington JJ, Guo M, Maeda Y. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1. EBioMedicine. 2022;75:103806. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103806 (Epub 2022 Jan 6).","journal-title":"EBioMedicine"},{"key":"392_CR83","doi-asserted-by":"publisher","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472\u2013477. https:\/\/doi.org\/10.1038\/s41586-021-03767-x. Epub 2021 Jul 8.","DOI":"10.1038\/s41586-021-03767-x"},{"key":"392_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s10038-021-01009-6","volume":"11","author":"M Chamnanphon","year":"2022","unstructured":"Chamnanphon M, Pongpanich M, Suttichet TB, Jantarabenjakul W, Torvorapanit P, Putcharoen O, Sodsai P, Phokaew C, Hirankarn N, Chariyavilaskul P, Shotelersuk V. Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population. J Hum Genet. 2022;11:1\u20137. https:\/\/doi.org\/10.1038\/s10038-021-01009-6.","journal-title":"J Hum Genet"},{"issue":"4","key":"392_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/vaccines5040042","volume":"5","author":"EG S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez EG, P\u00e9rez-N\u00fa\u00f1ez D, Revilla Y. Mechanisms of entry and endosomal pathway of African swine fever virus. Vaccines (Basel). 2017;5(4):42. https:\/\/doi.org\/10.3390\/vaccines5040042.","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"392_CR86","doi-asserted-by":"publisher","first-page":"e024004","DOI":"10.1161\/JAHA.121.024004","volume":"11","author":"JA Regan","year":"2022","unstructured":"Regan JA, Abdulrahim JW, Bihlmeyer NA, Haynes C, Kwee LC, Patel MR, Shah SH. Phenome-wide association study of severe COVID-19 genetic risk variants. J Am Heart Assoc. 2022;11(5):e024004. https:\/\/doi.org\/10.1161\/JAHA.121.024004.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"392_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2350-4-9","volume":"12","author":"M Lin","year":"2003","unstructured":"Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;12(4):9. https:\/\/doi.org\/10.1186\/1471-2350-4-9.","journal-title":"BMC Med Genet"},{"issue":"17","key":"392_CR88","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMra1100030","volume":"365","author":"JH Cho","year":"2011","unstructured":"Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med. 2011;365(17):1612\u201323. https:\/\/doi.org\/10.1056\/NEJMra1100030.","journal-title":"N Engl J Med"},{"issue":"5","key":"392_CR89","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/jmv.25018","volume":"90","author":"M Dutta","year":"2018","unstructured":"Dutta M, Dutta P, Medhi S, Borkakoty B, Biswas D. Polymorphism of HLA class I and class II alleles in influenza A(H1N1)pdm09 virus infected population of Assam Northeast India. J Med Virol. 2018;90(5):854\u201360. https:\/\/doi.org\/10.1002\/jmv.25018.","journal-title":"J Med Virol"},{"key":"392_CR90","doi-asserted-by":"publisher","first-page":"308237","DOI":"10.1155\/2012\/308237","volume":"2012","author":"Y Ma","year":"2012","unstructured":"Ma Y, Yuan B, Yi J, Zhuang R, Wang J, Zhang Y, et al. The genetic polymorphisms of HLA are strongly correlated with the disease severity after Hantaan virus infection in the Chinese Han population. Clin Dev Immunol. 2012;2012:308237. https:\/\/doi.org\/10.1155\/2012\/308237 (Epub 2012 Oct 8).","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"392_CR91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40001-021-00563-1","volume":"26","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res. 2021;26(1):84. https:\/\/doi.org\/10.1186\/s40001-021-00563-1.","journal-title":"Eur J Med Res"},{"key":"392_CR92","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.eclinm.2021.101099","volume":"40","author":"J Weiner","year":"2021","unstructured":"Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, M\u00fcller M, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;40:101099. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101099 (Epub 2021 Sep 2).","journal-title":"EClinicalMedicine"},{"issue":"9","key":"392_CR93","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/genes11091010","volume":"11","author":"A Latini","year":"2020","unstructured":"Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P, et al. COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes (Basel). 2020;11(9):1010. https:\/\/doi.org\/10.3390\/genes11091010.","journal-title":"Genes (Basel)"},{"issue":"2","key":"392_CR94","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (Epub 2020 Mar 5).","journal-title":"Cell"},{"issue":"2","key":"392_CR95","doi-asserted-by":"publisher","first-page":"103333","DOI":"10.1016\/j.retram.2022.103333","volume":"70","author":"A David","year":"2022","unstructured":"David A, Parkinson N, Peacock TP, Pairo-Castineira E, Khanna T, Cobat A, et al. A common TMPRSS2 variant has a protective effect against severe COVID-19. Curr Res Transl Med. 2022;70(2):103333. https:\/\/doi.org\/10.1016\/j.retram.2022.103333.","journal-title":"Curr Res Transl Med"},{"key":"392_CR96","doi-asserted-by":"publisher","first-page":"105206","DOI":"10.1016\/j.meegid.2022.105206","volume":"98","author":"RK Pandey","year":"2022","unstructured":"Pandey RK, Srivastava A, Singh PP, Chaubey G. Genetic association of TMPRSS2 rs2070788 polymorphism with COVID-19 case fatality rate among Indian populations. Infect Genet Evol. 2022;98:105206. https:\/\/doi.org\/10.1016\/j.meegid.2022.105206 (Epub 2022 Jan 5).","journal-title":"Infect Genet Evol"},{"issue":"4","key":"392_CR97","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41419-021-03513-1","volume":"12","author":"G Novelli","year":"2021","unstructured":"Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, et al. Inhibition of HECT E3 ligases as potential therapy for COVID-19. Cell Death Dis. 2021;12(4):310. https:\/\/doi.org\/10.1038\/s41419-021-03513-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"392_CR98","doi-asserted-by":"publisher","first-page":"20837","DOI":"10.1038\/s41598-021-99952-z","volume":"11","author":"AT Freitas","year":"2021","unstructured":"Freitas AT, Calhau C, Antunes G, Ara\u00fajo B, Bandeira M, Barreira S, et al. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep. 2021;11(1):20837. https:\/\/doi.org\/10.1038\/s41598-021-99952-z.","journal-title":"Sci Rep"},{"issue":"1","key":"392_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41590-021-01080-3","volume":"23","author":"D Chauss","year":"2022","unstructured":"Chauss D, Freiwald T, McGregor R, Yan B, Wang L, Nova-Lamperti E, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat Immunol. 2022;23(1):62\u201374. https:\/\/doi.org\/10.1038\/s41590-021-01080-3 (Epub 2021 Nov 11).","journal-title":"Nat Immunol"},{"key":"392_CR100","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.8538","author":"AM Hung","year":"2022","unstructured":"Hung AM, Shah SC, Bick AG, Yu Z, Chen HC, Hunt CM, et al. APOL1 Risk variants, acute kidney injury, and death in participants with African ancestry hospitalized With COVID-19 from the million veteran program. JAMA Intern Med. 2022. https:\/\/doi.org\/10.1001\/jamainternmed.2021.8538.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"392_CR101","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","volume":"23","author":"M Stravalaci","year":"2022","unstructured":"Stravalaci M, Pagani I, Paraboschi EM, Pedotti M, Doni A, Scavello F, et al. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules. Nat Immunol. 2022;23(2):275\u201386. https:\/\/doi.org\/10.1038\/s41590-021-01114-w (Epub 2022 Jan 31).","journal-title":"Nat Immunol"},{"issue":"7","key":"392_CR102","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184(7):1671\u201392. https:\/\/doi.org\/10.1016\/j.cell.2021.02.029 (Epub 2021 Feb 16).","journal-title":"Cell"},{"issue":"12","key":"392_CR103","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","volume":"40","author":"B Beutler","year":"2004","unstructured":"Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40(12):845\u201359. https:\/\/doi.org\/10.1016\/j.molimm.2003.10.005.","journal-title":"Mol Immunol"},{"issue":"1","key":"392_CR104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41435-021-00157-1","volume":"23","author":"S Mantovani","year":"2022","unstructured":"Mantovani S, Daga S, Fallerini C, Baldassarri M, Benetti E, Picchiotti N, et al. Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients. Genes Immun. 2022;23(1):51\u20136. https:\/\/doi.org\/10.1038\/s41435-021-00157-1 (Epub 2021 Dec 24).","journal-title":"Genes Immun"},{"issue":"10","key":"392_CR105","doi-asserted-by":"publisher","first-page":"e67569","DOI":"10.7554\/eLife.67569","volume":"2","author":"C Fallerini","year":"2021","unstructured":"Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D, et al. Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife. 2021;2(10):e67569. https:\/\/doi.org\/10.7554\/eLife.67569.","journal-title":"Elife"},{"issue":"62","key":"392_CR106","doi-asserted-by":"publisher","first-page":"eab14348","DOI":"10.1126\/sciimmunol.abl4348","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6(62):eab14348. https:\/\/doi.org\/10.1126\/sciimmunol.abl4348.","journal-title":"Sci Immunol"},{"issue":"12","key":"392_CR107","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.jid.2021.05.024","volume":"141","author":"LM Arkin","year":"2021","unstructured":"Arkin LM, Moon JJ, Tran JM, Asgari S, O\u2019Farrelly C, Casanova JL, et al. From your nose to your toes: a review of severe acute respiratory syndrome coronavirus 2 pandemic-associated pernio. J Invest Dermatol. 2021;141(12):2791\u20136. https:\/\/doi.org\/10.1016\/j.jid.2021.05.024 (Epub 2021 Jul 15).","journal-title":"J Invest Dermatol"},{"issue":"6515","key":"392_CR108","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585. https:\/\/doi.org\/10.1126\/science.abd4585.","journal-title":"Science"},{"issue":"6515","key":"392_CR109","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. https:\/\/doi.org\/10.1126\/science.abd4570.","journal-title":"Science"},{"issue":"628","key":"392_CR110","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1126\/scitranslmed.abj7521","volume":"14","author":"R Carapito","year":"2022","unstructured":"Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, et al. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med. 2022;14(628):7521. https:\/\/doi.org\/10.1126\/scitranslmed.abj7521.","journal-title":"Sci Transl Med"},{"issue":"11","key":"392_CR111","doi-asserted-by":"publisher","first-page":"595478","DOI":"10.3389\/fimmu.2020.595478","volume":"5","author":"P Bastard","year":"2020","unstructured":"Bastard P, Galerne A, Lefevre-Utile A, Briand C, Baruchel A, Durand P, et al. Different clinical presentations and outcomes of disseminated varicella in children with primary and acquired immunodeficiencies. Front Immunol. 2020;5(11):595478. https:\/\/doi.org\/10.3389\/fimmu.2020.595478.","journal-title":"Front Immunol"},{"issue":"4","key":"392_CR112","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41591-021-01281-1","volume":"27","author":"S Zhou","year":"2021","unstructured":"Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021;27(4):659\u201367. https:\/\/doi.org\/10.1038\/s41591-021-01281-1 (Epub 2021 Feb 25).","journal-title":"Nat Med"},{"issue":"60","key":"392_CR113","doi-asserted-by":"publisher","first-page":"eabf9564","DOI":"10.1126\/sciimmunol.abf9564","volume":"6","author":"T Magg","year":"2021","unstructured":"Magg T, Okano T, Koenig LM, Boehmer DFR, Schwartz SL, Inoue K, et al. Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency. Sci Immunol. 2021;6(60):eabf9564. https:\/\/doi.org\/10.1126\/sciimmunol.abf9564.","journal-title":"Sci Immunol"},{"issue":"2","key":"392_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41588-021-00996-8","volume":"54","author":"JE Huffman","year":"2022","unstructured":"Huffman JE, Butler-Laporte G, Khan A, Pairo-Castineira E, Drivas TG, Peloso GM, et al. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nat Genet. 2022;54(2):125\u20137. https:\/\/doi.org\/10.1038\/s41588-021-00996-8 (Epub 2022 Jan 13).","journal-title":"Nat Genet"},{"issue":"2","key":"392_CR115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41588-021-00986-w","volume":"54","author":"JF Shelton","year":"2022","unstructured":"Shelton JF, Shastri AJ, Fletez-Brant K, 23andMe COVID-19 Team, Aslibekyan S, Auton A. The UGT2A1\/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nat Genet. 2022;54(2):121\u20134. https:\/\/doi.org\/10.1038\/s41588-021-00986-w.","journal-title":"Nat Genet"},{"key":"392_CR116","unstructured":"e!Ensembl (2022). Retrieved 19\/04, 2022 from https:\/\/www.ensembl.org."},{"key":"392_CR117","doi-asserted-by":"publisher","first-page":"107602962110566","DOI":"10.1177\/10760296211056648","volume":"28","author":"B Kantarcioglu","year":"2022","unstructured":"Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, et al. An Update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations. Clin Appl Thromb Hemost. 2022;28:10760296211056648. https:\/\/doi.org\/10.1177\/10760296211056648.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"392_CR118","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2110475 (Epub 2021 Aug 25).","journal-title":"N Engl J Med"},{"issue":"1","key":"392_CR119","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41467-022-28936-y","volume":"13","author":"M Levine-Tiefenbrun","year":"2022","unstructured":"Levine-Tiefenbrun M, Yelin I, Alapi H, Herzel E, Kuint J, Chodick G, et al. Waning of SARS-CoV-2 booster viral-load reduction effectiveness. Nat Commun. 2022;13(1):1237. https:\/\/doi.org\/10.1038\/s41467-022-28936-y.","journal-title":"Nat Commun"},{"key":"392_CR120","doi-asserted-by":"publisher","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u2013154. https:\/\/doi.org\/10.1038\/s41579-020-00459-7. Epub 2020 Oct 6. Erratum in: Nat Rev Microbiol. 2022 Feb 23.","DOI":"10.1038\/s41579-020-00459-7"},{"issue":"11","key":"392_CR121","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","volume":"27","author":"A Choi","year":"2021","unstructured":"Choi A, Koch M, Wu K, Chu L, Ma L, Hill A, et al. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis. Nat Med. 2021Nov;27(11):2025\u201331. https:\/\/doi.org\/10.1038\/s41591-021-01527-y (Epub 2021 Sep 15).","journal-title":"Nat Med"},{"issue":"10316","key":"392_CR122","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","volume":"398","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Cohen C, Hern\u00e1n MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093\u2013100. https:\/\/doi.org\/10.1016\/S0140-6736(21)02249-2 (Epub 2021 Oct 29).","journal-title":"Lancet"},{"issue":"37","key":"392_CR123","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.15585\/mmwr.mm7037e1","volume":"70","author":"HM Scobie","year":"2021","unstructured":"Scobie HM, Johnson AG, Suthar AB, Severson R, Alden NB, Balter S, et al. Monitoring incidence of COVID-19 Cases, hospitalizations, and deaths, by vaccination status-13 U.S. jurisdictions, April 4-July 17, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1284\u201390.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 2","key":"392_CR124","doi-asserted-by":"publisher","first-page":"S278","DOI":"10.1016\/j.mjafi.2021.06.034","volume":"77","author":"J Muthukrishnan","year":"2021","unstructured":"Muthukrishnan J, Vardhan V, Mangalesh S, Koley M, Shankar S, Yadav AK, et al. Vaccination status and COVID-19 related mortality: a hospital based cross sectional study. Med J Armed Forces India. 2021;77(Suppl 2):S278\u201382. https:\/\/doi.org\/10.1016\/j.mjafi.2021.06.034 (Epub 2021 Jul 26).","journal-title":"Med J Armed Forces India"},{"issue":"9","key":"392_CR125","doi-asserted-by":"publisher","first-page":"352","DOI":"10.15585\/mmwr.mm7109e3","volume":"71","author":"NP Klein","year":"2022","unstructured":"Klein NP, Stockwell MS, Demarco M, Gaglani M, Kharbanda AB, Irving SA, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION network, 10 States, April 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(9):352\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"165","key":"392_CR126","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejca.2022.01.035","volume":"10","author":"P Heudel","year":"2022","unstructured":"Heudel P, Favier B, Solodky ML, Assaad S, Chaumard N, Tredan O, et al. Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients. Eur J Cancer. 2022;10(165):174\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.035.","journal-title":"Eur J Cancer"},{"issue":"2","key":"392_CR127","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/v14020307","volume":"14","author":"IM Citu","year":"2022","unstructured":"Citu IM, Citu C, Gorun F, Sas I, Tomescu L, Neamtu R, et al. Immunogenicity following administration of BNT162b2 and Ad26.COV2.S COVID-19 vaccines in the pregnant population during the third trimester. Viruses. 2022;14(2):307. https:\/\/doi.org\/10.3390\/v14020307.","journal-title":"Viruses"},{"key":"392_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27666","author":"N Busic","year":"2022","unstructured":"Busic N, Lucijanic T, Barsic B, Luksic I, Busic I, Kurdija G, et al. Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: Differences between vector and mRNA vaccines. J Med Virol. 2022. https:\/\/doi.org\/10.1002\/jmv.27666.","journal-title":"J Med Virol"},{"issue":"7","key":"392_CR129","doi-asserted-by":"publisher","first-page":"255","DOI":"10.15585\/mmwr.mm7107e2","volume":"71","author":"JM Ferdinands","year":"2022","unstructured":"Ferdinands JM, Rao S, Dixon BE, Mitchell PK, DeSilva MB, Irving SA, et al. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):255\u201363.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"392_CR130","unstructured":"WHO. World Health Organization. Who.int \u201cwho.int\u201d.2022; Retrieved 19\/04, 2022, from https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"issue":"6584","key":"392_CR131","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/381667a0","volume":"381","author":"T Dragic","year":"1996","unstructured":"Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381(6584):667\u201373. https:\/\/doi.org\/10.1038\/381667a0.","journal-title":"Nature"},{"key":"392_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF02984134","volume":"59","author":"JBS Haldane","year":"1964","unstructured":"Haldane JBS, Jayakar SD. Equilibria under natural selection. J Genet. 1964;59:29\u201336.","journal-title":"J Genet"},{"issue":"5","key":"392_CR133","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1182\/blood.V54.5.961.961","volume":"54","author":"L Luzzatto","year":"1979","unstructured":"Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood. 1979;54(5):961\u201376.","journal-title":"Blood"},{"issue":"190","key":"392_CR134","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/190576a0","volume":"13","author":"S Brenner","year":"1961","unstructured":"Brenner S, Jacob F, Meselson M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature. 1961;13(190):576\u201381. https:\/\/doi.org\/10.1038\/190576a0.","journal-title":"Nature"},{"issue":"2","key":"392_CR135","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1708\/3790.37742","volume":"57","author":"GL Bersani","year":"2022","unstructured":"Bersani GL. altra epidemia [The parallel epidemic.]. Riv Psichiatr. 2022;57(2):101\u20135. https:\/\/doi.org\/10.1708\/3790.37742.","journal-title":"Riv Psichiatr"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-022-00392-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-022-00392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:10:11Z","timestamp":1654067411000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-022-00392-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/s40246-022-00392-1","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}